ANAPTYSBIO INC (ANAB:NASDAQ)
$54.84 -0.83 (-1.4909%)
Analysed ANAPTYSBIO INC (ANAB:NASDAQ) News Sources
Why These Four Biotech Stocks Prove That Follow-On Entries Still Pop Up In Stock Market Leaders
08-05-2026
yahoo.com
Is AnaptysBio (ANAB) One of the Best Performing Healthcare Stocks so Far in 2026?
10-05-2026
yahoo.com
Assessing AnaptysBio (ANAB) Valuation After Royalty Pivot Spinoff And Legal Outcome
11-05-2026
yahoo.com
Anaptys Appoints Chris Murphy as Chief Financial Officer and Owen Hughes to Board of Directors
11-05-2026
yahoo.com
RCKT Stock Down on Q1 Earnings Miss, Kresladi Launch in Focus
11-05-2026
yahoo.com
Anaptys Announces First Quarter 2026 Financial Results and Provides Business Update
12-05-2026
yahoo.com
AnaptysBio (ANAB) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
14-05-2026
yahoo.com
How The Grupo Traxión (BMV:TRAXION A) Story Is Shifting With Cautious New Analyst Targets
15-05-2026
yahoo.com
Wall Street Analysts See a 38.75% Upside in AnaptysBio (ANAB): Can the Stock Really Move This High?
19-05-2026
yahoo.com
Is AnaptysBio (ANAB) Outperforming Other Medical Stocks This Year?
21-05-2026
yahoo.com
What is the current price of ANAPTYSBIO INC (ANAB:NASDAQ)?
The current price of ANAPTYSBIO INC (ANAB:NASDAQ) is $54.84.
ANAPTYSBIO INC (ANAB:NASDAQ) absolute price change since previous trading day?
The absolute price change of ANAPTYSBIO INC (ANAB:NASDAQ) since the previous trading day is $-0.83.
ANAPTYSBIO INC (ANAB:NASDAQ) percentage price change since previous trading day?
The percentage price change of ANAPTYSBIO INC (ANAB:NASDAQ) since the previous trading day is -1.4909%.
What is the most recent average sentiment score for ANAPTYSBIO INC (ANAB:NASDAQ)?
The most recent average sentiment score for ANAPTYSBIO INC (ANAB:NASDAQ) is 60 out of 100.
What is the most recent average sentiment for ANAPTYSBIO INC (ANAB:NASDAQ)?
The most recent sentiment for ANAPTYSBIO INC (ANAB:NASDAQ) is .
SEC-8K** Filing Available For ANAPTYSBIO INC (ANAB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.